| 2025-10-29 |
TRFQ33483574 |
STRIVE PHARMACEUTICALS |
3050.0 kg |
711719.0
|
PHENAZOPYRIDINE HCL TABLETS USP . MG EACH F FILM COATED TABLET CONTAINS HSN CODE : - AS PER INVOICE |
| 2025-10-29 |
TRFQ33483579 |
GERICARE PHARMACEUTICAL SCORP |
14048.0 kg |
291800.0
|
SENNOSIDES & DOCUSATE SODIUM TABLET HSN CODE : - AS PER INVOICE |
| 2025-09-23 |
TRFQ33483561 |
GERICARE PHARMACEUTICAL SCORP |
15804.0 kg |
291800.0
|
SENNOSIDES & DOCUSATE SODIUM TABLET HSN CODE : - AS PER INVOICE |
| 2025-07-15 |
TRFQ33483459 |
PL DEVELPOMENTS |
14771.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50M8.6MG/50MG (RED) , (ORANGE) , ASPIRIN TABLETS USP 81MG , ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABLET 500/25MG - HSN CODE : 30049039 AS PER INVOI |
| 2025-07-09 |
TRFQ33483445 |
PL DEVELPOMENTS |
14339.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50M8.6MG/50MG (RED), TABLET 8.6MG/50MG (ORANGE) , 108 DRUM ( 06 PALLET ) ASPIRIN TABLETS USP 81MG - HSN CODE :30049039 - AS PER INVOICE |
| 2025-07-01 |
TRFQ33483433 |
PL DEVELPOMENTS |
3803.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50M8.6MG/50MG (RED), ASPIRIN TABLETS USP 81MG, &ITC HS CODE :30049039 |
| 2025-07-01 |
TRFQ33483432 |
PL DEVELPOMENTS |
16589.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM (RED) , TABLET 88.6MG/50MG (ORANGE) , ACETAMINOPHEN & DIPHENHYDRAMINE - ITC(HS) CODE :30049039 AS PER INVOICE |
| 2025-06-30 |
TRFQ33483440 |
PL DEVELPOMENTS |
19352.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50M8.6MG/50MG (RED), SENNOSIDES TABLET 8.6MG (BROWN), ACETAMINOPHEN & DIPHENHYDRAMINE - HSCODE :30049039 AS PER INVOICE |
| 2025-06-11 |
TRFQ33483426 |
PL DEVELPOMENTS |
13077.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM (RED), SENNOSIDESENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50MG (ORANGE), ACETAMINOPHEN & DIPHENHYDRAMINE - HS CODE :30049039 |
| 2025-06-11 |
TRFQ33483421 |
PL DEVELPOMENTS |
16032.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50M8.6MG/50MG (RED) , SENNOSIDES TABLET 8.6MG (BROWN), ACETAMINOPHEN & DIPHENHYDRAMINE - HSCODE :30049039 AS PER INVOICE |
| 2025-05-14 |
TRFQ33483322 |
STRIVE PHARMACEUTICALS |
8665.0 kg |
300490
|
DIPHENHYDRAMINE HYDROCHLORIDE PINK 25MG & ACEACETAMINOPHEN 250MG, ASPIRIN 250MG & CAFFEINE65MG TABLETS USP & DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE USP 25MG -HS CODE :30049039 |
| 2025-05-14 |
TRFQ33483336 |
PL DEVELPOMENTS |
14290.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50M8.6MG/50MG (RED), ASPIRIN TABLETS USP 81MG, SENNOSIDES TABLET 8.6MG (BROWN) - HS CODE :30049039 AS PER INVOICE |
| 2025-05-14 |
TRFQ33483404 |
PL DEVELPOMENTS |
14339.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50M8.6MG/50MG (RED) & ASPIRIN TABLETS USP 81MG &ITC(HS) CODE :30049039 AS PER INVOICE |
| 2025-04-22 |
TRFQ33483318 |
PL DEVELPOMENTS |
17560.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50M8.6MG/50MG (RED) , TABLET 8.6MG/50MG (ORANGE), HSN CODE : 30049039 AS PER INVOICE |
| 2025-03-29 |
MOSJAMDHBL24147 |
VIVUNT PHARMA LLC |
2808.0 kg |
300490
|
HS CODE 30049039 PHARMACEUTICAL PRODUCTS |
| 2025-03-27 |
TRFQ33483282 |
STRIVE PHARMACEUTICALS |
5878.0 kg |
300490
|
DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE USP 25M25MG & SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50MG (RED) & (BROWN),BISACODYL ASPIRIN TABLETS USP 81MG, HSN CODE - 3004903 AS PER INVOI |
| 2025-03-19 |
TRFQ33483278 |
STRIVE PHARMACEUTICALS |
16531.0 kg |
310510
|
DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE USP 25M25MG & TABLETS PINK 25MG, TABLETS BLUE 25MG, ACETAMINOPHEN 250MG, ASPIRIN 250MG & CAFFEINE65MG TABLETS USP - :30049039 AS PER INV |
| 2025-03-11 |
TRFQ33483264 |
PL DEVELPOMENTS |
16358.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50M8.6MG/50MG (RED), ASPIRIN TABLETS USP 81MG, ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABLET 500/25MG - HS) CODE :30049039 |
| 2025-02-09 |
TRFQ33483249 |
PL DEVELPOMENTS |
14330.0 kg |
300490
|
SENNOSIDES & DOCUSATE , ASPIRIN TABLETS USP 881MG, SENNOSIDES TABLET 8.6MG (BROWN), SENNOSIDES & DOCUSATE SODIUM - HS CODE :30049039 - AS PER INVOICE |
| 2025-01-28 |
TRFQ33483237 |
PL DEVELPOMENTS |
19522.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50M8.6MG/50MG (RED), ACETAMINOPHEN & DIPHENHYDRAMINE - HS CODE :30049039 |
| 2025-01-15 |
TRFQ33483223 |
PL DEVELPOMENTS |
17118.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM, ACETAMINOPHEN &DIPHENHYDRAMINE, SENNOSIDES TABLET, SENNOSIDES & DOCUSATE SODIUM - HS CODE :30049039 AS PER INVOIE |
| 2025-01-12 |
TRFQ33483217 |
STRIVE PHARMACEUTICALS |
19784.0 kg |
300490
|
DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE USP 25M25MG, DIPHENHYDRAMINE HYDROCHLORIDE TABLETS PINK 25MG, PHENAZOPYRIDINE HCL TABLETS USP 99.5MG, - ITC(HS) CODE :30049039 , AS PER INVOICE |
| 2025-01-05 |
SWJTCHE2404005 |
KING KUTTER INC |
18753.0 kg |
291800
|
SENNOSIDES & DOCUSATE SODIUM TABLET ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABLET |
| 2024-12-15 |
TRFQ33483187 |
PL DEVELPOMENTS |
17159.0 kg |
300490
|
SENNOSIDES & DOCUSATESODIUM TABLET 8.6MG/50MG8.6MG/50MG(RED & ASPIRIN TABLETS USP 81MG & ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABLET 500/25MG HSC CODE : 30049039 |
| 2024-12-02 |
COSU639901870001 |
STRIVE PHARMACEUTICALS |
16652.0 kg |
291229
|
DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE USP 25MG |
| 2024-11-25 |
TRFQ33483173 |
STRIVE PHARMACEUTICALS |
15260.0 kg |
300490
|
DIPHENHYDRAMINE HYDROCHLORIDE , ASPIRIN TABLETABLETS USP 81MG, PHENAZOPYRIDINE HCL TABLETSUSP 99.5MG, BISACODYL TABLETS USP 5MG, ACETAMINOPHEN - H.S CODE : 30049039 |
| 2024-11-06 |
TRFQ33483144 |
PL DEVELPOMENTS |
17560.0 kg |
300490
|
SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50M8.6MG/50MG (ORANGE) & SENNOSIDES & DOCUSATE SODIUM TABLET 8.6MG/50MG (RED) - HSN CODE : 30049039 |
| 2024-10-09 |
TRFQ33483125 |
STRIVE PHARMACEUTICALS |
15367.0 kg |
300490
|
DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE USP 25M25MG , BISACODYL TABLETS USP 5MG, ACETAMINOPHEN 250MG,, ASPIRIN TABLETS USP 81MG - HSN CODE 30049039 AS PER INVOICE |
| 2024-07-04 |
TRFQ33483038 |
PL DEVELPOMENTS |
15047.0 kg |
291800
|
SENNOSIDES & DOCUSATE SODIUM , SENNOSIDES TABTABLET 8.6MG (BROWN), ASPIRIN TABLETS USP 81MG - 30049039 |
| 2024-06-22 |
TRFQ33483032 |
STRIVE PHARMACEUTICALS |
9740.0 kg |
291822
|
ACETAMINOPHEN 250MG, ASPIRIN - 30049039 - AS PER INVOICE |
| 2024-06-02 |
TRFQ33483023 |
STRIVE PHARMACEUTICALS |
18746.0 kg |
310510
|
ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE USP 25MG, PHENAZOPYRIDINE HCL TABLETS USP 99.5MG - 30049039 |